Evaluation of available in vitro 99mTc-RBC labeling techniques: A Canadian perspective

E Toda, M Ginj - Journal of Nuclear Medicine Technology, 2014 - Soc Nuclear Med
Asignificant challenge for the Canadian nuclear medicine community is the single sourcing
for most kits and ready-to-use radiopharmaceuticals. The main causes are the small size of …

Validation of a commercial Gluceptate kit for in vitro Tc-99m labeling of red blood cells

P Zabel, P Hogg, S Lourie - 2011 - Soc Nuclear Med
1649 Objectives In vivo Tc-99m labeling of red blood cells (RBC) is primarily used for gated
blood pool studies but can suffer from low labeling efficiences (LE)/drug interferences. In …

Miniaturized chromatography system for Tc-99m labeled red blood cells.

K Krogman, B McKay, M Zimmer, L Riehle, G Dillehay - 2017 - Soc Nuclear Med
821 Objectives: According to red cell labeling kit package inserts, quality control procedures
for Tc-99m labeled red blood cells (RBCs) require centrifugation. Many nuclear medicine …

Improved modification for in vitro labeling of red blood cells with technetium-99m

B Gerson, JR Ballinger… - Journal of Nuclear …, 1988 - Soc Nuclear Med
We have tested a modification of the Brookhaven method for in vitro labeling of red blood
cells (RBCs) with technetium-99m by adding an initial centrifugation step and performing the …

[PDF][PDF] In vivo labeling of red blood cells with 99mTc: a new approach to blood pool visualization

DG Pavel, AM Zimmer… - Journal of Nuclear …, 1977 - Soc Nuclear Med
MATERIALSANDMETHODS Combinafion in vivo and in vitro study. The pun pose of this
phase was to determine an appropriate lag time between the injections of stannous pyro …

Effects on Red Blood Cell Labeling Protocols due to USP 797 revisions.

K Danberry, B Burton, CR McCleod - 2015 - Soc Nuclear Med
2738 Objectives Effective October 1, 2014 the state of Florida recognized the revisions that
United States Pharmacopeia (USP) applied to USP Chapter 797 on June 1, 2008, restricting …

Analysis of 99mTc-RBC labeling efficiency between modified in-vitro method and AMC method

JK Ryu, KR Dong, WY Jung, SK Shin, SM Cho… - Annals of Nuclear …, 2010 - Elsevier
The aim of this study was to increase the labeling efficiency of 99mTc-RBC. We compared
the clinical utility of the conventional modified in-vitro method (MIM) with our new AMC …

Cellular Labeling with 99mTc Chelates: Relevance of In Vitro and In Vivo Viability Testing

H Sinzinger, M Rodrigues - … : Preparation and quality control in nuclear …, 2007 - Springer
8.6 Conclusions Developments in both instrumentation and cell labeling have enabled a
great expansion of their use in both clinical practice and research. Studies with 99m Tc-RBC …

In vivo comparison of anticoagulant citrate dextrose versus heparin for use as an anticoagulant with the UltraTag® red blood cell kit

JF Wieseler, MW Gebhard, JC Hung… - Journal of nuclear …, 1994 - Soc Nuclear Med
Objective: The package insert for the UltraTag® RBC kit recommends the use of either
heparin or anticoagulant citrate dextrose (ACD) as an anticoagulant. A comparison study …

[CITATION][C] Evaluation of heparin and anticoagulant citrate dextrose in the preparation of technetium-99m-red blood cells with UltraTag® RBC kit

ME Wilson, JC Hung - Journal of Nuclear Medicine, 1992 - Soc Nuclear Med
RBC kit for radiolabeling RBCs. The package insert of the UltraTag® RBC kit recommends
collecting the patient's blood sample (1.0 to 3.0 ml) using either heparin or ACD …